BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 11956272)

  • 1. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
    Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
    J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials.
    Baquet CR; Ellison GL; Mishra SI
    J Clin Oncol; 2008 Jul; 26(20):3380-6. PubMed ID: 18612153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials.
    Baquet CR; Ellison GL; Mishra SI
    J Health Care Poor Underserved; 2009 May; 20(2 Suppl):120-34. PubMed ID: 19711497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
    Mishkin G; Minasian LM; Kohn EC; Noone AM; Temkin SM
    Gynecol Oncol; 2016 Dec; 143(3):611-616. PubMed ID: 27697287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
    Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
    J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights From Building a New National Cancer Institute Community Oncology Research Program Site.
    Saphner T; Thompson MA; Planton S; Singh M; Glandt N; Robinson L; DeBartolo J
    WMJ; 2016 Aug; 115(4):191-5. PubMed ID: 29099156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National cancer clinical trials: children have equal access; adolescents do not.
    Bleyer WA; Tejeda H; Murphy SB; Robison LL; Ross JA; Pollock BH; Severson RK; Brawley OW; Smith MA; Ungerleider RS
    J Adolesc Health; 1997 Dec; 21(6):366-73. PubMed ID: 9401854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
    Mantripragada KC; Olszewski AJ; Schumacher A; Perez K; Birnbaum A; Reagan JL; Mega A; Khurshid H; Bartley C; Lombardo A; Rossiter R; Papa A; Bakalarski P; Safran H
    J Oncol Pract; 2016 Apr; 12(4):e396-404. PubMed ID: 26907448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.
    Collins CL; Malvar J; Hamilton AS; Deapen DM; Freyer DR
    Cancer; 2015 Dec; 121(24):4398-406. PubMed ID: 26393950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2010 Nov; 16(22):5557-63. PubMed ID: 21062929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Representation of Asian Americans in clinical cancer trials.
    Alexander GA; Chu KC; Ho RC
    Ann Epidemiol; 2000 Nov; 10(8 Suppl):S61-67. PubMed ID: 11189094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
    Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
    Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.
    Movsas B; Moughan J; Owen J; Coia LR; Zelefsky MJ; Hanks G; Wilson JF
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1145-50. PubMed ID: 17418963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
    Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States.
    Parsons HM; Penn DC; Li Q; Cress RD; Pollock BH; Malogolowkin MH; Wun T; Keegan THM
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27426. PubMed ID: 30256525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2011 Apr; 17(7):1947-55. PubMed ID: 21447723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental treatment costs in national cancer institute-sponsored clinical trials.
    Goldman DP; Berry SH; McCabe MS; Kilgore ML; Potosky AL; Schoenbaum ML; Schonlau M; Weeks JC; Kaplan R; Escarce JJ
    JAMA; 2003 Jun; 289(22):2970-7. PubMed ID: 12799405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.